Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Protective KIR-HLA interactions for HCV infection in intravenous drug users.

Protective KIR-HLA interactions for HCV infection in intravenous drug users. Mol Immunol. 2009 Aug; 46(13):2723-7.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.